Michael Koren

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Kayvon Modjarrad, Leyi Lin, Sarah L. George et al. · The Lancet · 2017 · 193 citations · Full text

Vaccination, Vaccine Safety, Vaccinology +7

TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study

Ciarán P. Kelly, Joseph A. Murray, Daniel A. Leffler et al. · Gastroenterology · 2021 · 167 citations · Full text

Food Intolerance, Autoimmune Disease, Allergy +6

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi et al. · The Lancet · 2018 · 94 citations · Full text

Obesity, Metabolic Syndrome, Camellia-timi 61 +9

Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor

Vincent Dussupt, Rajeshwer S. Sankhala, Gregory D. Gromowski et al. · Nature Medicine · 2020 · 85 citations · Full text

Vaccination, Vaccine Target, Immunology +8

War Wound Treatment Complications Due to Transfer of an IncN Plasmid Harboring <i>bla</i> _OXA-181 from Morganella morganii to CTX-M-27-Producing Sequence Type 131 Escherichia coli

Patrick McGann, Erik Snesrud, Ana Ong et al. · Antimicrobial Agents and Chemotherapy · 2015 · 41 citations · Full text